235 related articles for article (PubMed ID: 34485611)
1. ImmTOR nanoparticles enhance AAV transgene expression after initial and repeat dosing in a mouse model of methylmalonic acidemia.
Ilyinskii PO; Michaud AM; Rizzo GL; Roy CJ; Leung SS; Elkins SL; Capela T; Chowdhury A; Li L; Chandler RJ; Manoli I; Andres-Mateos E; Johnston LPM; Vandenberghe LH; Venditti CP; Kishimoto TK
Mol Ther Methods Clin Dev; 2021 Sep; 22():279-292. PubMed ID: 34485611
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of liver-directed transgene expression at initial and repeat doses of AAV vectors admixed with ImmTOR nanoparticles.
Ilyinskii PO; Michaud AM; Roy CJ; Rizzo GL; Elkins SL; Capela T; Chowdhury AC; Leung SS; Kishimoto TK
Sci Adv; 2021 Feb; 7(9):. PubMed ID: 33627416
[TBL] [Abstract][Full Text] [Related]
3. Readministration of high-dose adeno-associated virus gene therapy vectors enabled by ImmTOR nanoparticles combined with B cell-targeted agents.
Ilyinskii PO; Roy C; Michaud A; Rizzo G; Capela T; Leung SS; Kishimoto TK
PNAS Nexus; 2023 Nov; 2(11):pgad394. PubMed ID: 38024395
[TBL] [Abstract][Full Text] [Related]
4. Development of ImmTOR Tolerogenic Nanoparticles for the Mitigation of Anti-drug Antibodies.
Kishimoto TK
Front Immunol; 2020; 11():969. PubMed ID: 32508839
[TBL] [Abstract][Full Text] [Related]
5. Promoterless, Nuclease-Free Genome Editing Confers a Growth Advantage for Corrected Hepatocytes in Mice With Methylmalonic Acidemia.
Chandler RJ; Venturoni LE; Liao J; Hubbard BT; Schneller JL; Hoffmann V; Gordo S; Zang S; Ko CW; Chau N; Chiang K; Kay MA; Barzel A; Venditti CP
Hepatology; 2021 Jun; 73(6):2223-2237. PubMed ID: 32976669
[TBL] [Abstract][Full Text] [Related]
6. Rapamycin nanoparticles increase the therapeutic window of engineered interleukin-2 and drive expansion of antigen-specific regulatory T cells for protection against autoimmune disease.
Kishimoto TK; Fournier M; Michaud A; Rizzo G; Roy C; Capela T; Nukolova N; Li N; Doyle L; Fu FN; VanDyke D; Traber PG; Spangler JB; Leung SS; Ilyinskii PO
J Autoimmun; 2023 Oct; 140():103125. PubMed ID: 37844543
[TBL] [Abstract][Full Text] [Related]
7. Central nervous system-targeted adeno-associated virus gene therapy in methylmalonic acidemia.
May FJ; Head PE; Venturoni LE; Chandler RJ; Venditti CP
Mol Ther Methods Clin Dev; 2021 Jun; 21():765-776. PubMed ID: 34169115
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of the Tolerogenic Phenotype in the Liver by ImmTOR Nanoparticles.
Ilyinskii PO; Roy CJ; LePrevost J; Rizzo GL; Kishimoto TK
Front Immunol; 2021; 12():637469. PubMed ID: 34113339
[TBL] [Abstract][Full Text] [Related]
9. Systemic gene therapy for methylmalonic acidemia using the novel adeno-associated viral vector 44.9.
Chandler RJ; Di Pasquale G; Sloan JL; McCoy S; Hubbard BT; Kilts TM; Manoli I; Chiorini JA; Venditti CP
Mol Ther Methods Clin Dev; 2022 Dec; 27():61-72. PubMed ID: 36186952
[TBL] [Abstract][Full Text] [Related]
10. Rescue of infant progressive familial intrahepatic cholestasis type 3 mice by repeated dosing of AAV gene therapy.
Weber ND; Odriozola L; Ros-Gañán I; García-Porrero G; Salas D; Argemi J; Combal JP; Kishimoto TK; González-Aseguinolaza G
JHEP Rep; 2023 May; 5(5):100713. PubMed ID: 37096142
[TBL] [Abstract][Full Text] [Related]
11.
Schneller JL; Lee CM; Venturoni LE; Chandler RJ; Li A; Myung S; Cradick TJ; Hurley AE; Lagor WR; Bao G; Venditti CP
Mol Ther Methods Clin Dev; 2021 Dec; 23():619-632. PubMed ID: 34901307
[TBL] [Abstract][Full Text] [Related]
12. Tolerogenic nanoparticles mitigate the formation of anti-drug antibodies against pegylated uricase in patients with hyperuricemia.
Sands E; Kivitz A; DeHaan W; Leung SS; Johnston L; Kishimoto TK
Nat Commun; 2022 Jan; 13(1):272. PubMed ID: 35022448
[TBL] [Abstract][Full Text] [Related]
13. Novel AAV-mediated genome editing therapy improves health and survival in a mouse model of methylmalonic acidemia.
Zhang S; Bastille A; Gordo S; Ramesh N; Vora J; McCarthy E; Zhang X; Frank D; Ko CW; Wu C; Walsh N; Amarwani S; Liao J; Xiong Q; Drouin L; Hebben M; Chiang K; Chau BN
PLoS One; 2022; 17(9):e0274774. PubMed ID: 36126056
[TBL] [Abstract][Full Text] [Related]
14. Neutralizing Antibodies Against Adeno-Associated Viral Capsids in Patients with mut Methylmalonic Acidemia.
Harrington EA; Sloan JL; Manoli I; Chandler RJ; Schneider M; McGuire PJ; Calcedo R; Wilson JM; Venditti CP
Hum Gene Ther; 2016 May; 27(5):345-53. PubMed ID: 26790480
[TBL] [Abstract][Full Text] [Related]
15. Subretinal delivery of adeno-associated virus serotype 2 results in minimal immune responses that allow repeat vector administration in immunocompetent mice.
Barker SE; Broderick CA; Robbie SJ; Duran Y; Natkunarajah M; Buch P; Balaggan KS; MacLaren RE; Bainbridge JW; Smith AJ; Ali RR
J Gene Med; 2009 Jun; 11(6):486-97. PubMed ID: 19340848
[TBL] [Abstract][Full Text] [Related]
16. B cell focused transient immune suppression protocol for efficient AAV readministration to the liver.
Rana J; Herzog RW; Muñoz-Melero M; Yamada K; Kumar SRP; Lam AK; Markusic DM; Duan D; Terhorst C; Byrne BJ; Corti M; Biswas M
Mol Ther Methods Clin Dev; 2024 Mar; 32(1):101216. PubMed ID: 38440160
[TBL] [Abstract][Full Text] [Related]
17. Immune responses to adeno-associated virus vectors.
Zaiss AK; Muruve DA
Curr Gene Ther; 2005 Jun; 5(3):323-31. PubMed ID: 15975009
[TBL] [Abstract][Full Text] [Related]
18. Tricarboxylic acid cycle enzyme activities in a mouse model of methylmalonic aciduria.
Wongkittichote P; Cunningham G; Summar ML; Pumbo E; Forny P; Baumgartner MR; Chapman KA
Mol Genet Metab; 2019 Dec; 128(4):444-451. PubMed ID: 31648943
[TBL] [Abstract][Full Text] [Related]
19. Influence of Pre-existing Anti-capsid Neutralizing and Binding Antibodies on AAV Vector Transduction.
Fitzpatrick Z; Leborgne C; Barbon E; Masat E; Ronzitti G; van Wittenberghe L; Vignaud A; Collaud F; Charles S; Simon Sola M; Jouen F; Boyer O; Mingozzi F
Mol Ther Methods Clin Dev; 2018 Jun; 9():119-129. PubMed ID: 29766022
[TBL] [Abstract][Full Text] [Related]
20. Enhancing transduction of the liver by adeno-associated viral vectors.
Nathwani AC; Cochrane M; McIntosh J; Ng CY; Zhou J; Gray JT; Davidoff AM
Gene Ther; 2009 Jan; 16(1):60-9. PubMed ID: 18701909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
